Here, we found that high transcription levels of CLEC3B were correlated with the overall survival of HCC patients as well as disease-specific survival, suggesting that high levels of CLEC3B mRNA are beneficial to the survival of HCC patients and may improve the resistance of patients to other diseases to a certain extent. The gene discussed is CLEC3B; the disease is hepatocellular carcinoma.